Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2003 | 07-2003 | 06-2003 | 04-2003 | 03-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,728 | 161 | -5,306 | 503 | -1,617 |
| Depreciation Amortization | 5,954 | 486 | 2,143 | 282 | 115 |
| Income taxes - deferred | N/A | -65 | N/A | -181 | N/A |
| Accounts receivable | 1,314 | 355 | 1,455 | 396 | -12 |
| Accounts payable and accrued liabilities | -575 | 504 | 452 | 134 | 189 |
| Other Working Capital | -825 | 1,059 | 938 | 837 | -190 |
| Other Operating Activity | -739 | -859 | -1,907 | -530 | -177 |
| Operating Cash Flow | $-5,599 | $1,641 | $-2,225 | $1,441 | $-1,692 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -19 | -253 | -19 | -141 | N/A |
| Sale Of Investment | 520 | N/A | 520 | N/A | 520 |
| Purchase Sale Intangibles | -178 | N/A | -161 | N/A | -18 |
| Other Investing Activity | -338 | 0 | -321 | 0 | -18 |
| Investing Cash Flow | $163 | $-253 | $180 | $-141 | $502 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 245 | N/A | 170 | N/A |
| Debt Issued | 7,750 | N/A | 5,426 | N/A | 3,100 |
| Debt Repayment | N/A | -524 | -440 | -230 | -440 |
| Common Stock Issued | 1,178 | N/A | N/A | N/A | N/A |
| Common Stock Repurchased | N/A | N/A | -83 | N/A | -49 |
| Other Financing Activity | -687 | 0 | -455 | 0 | -268 |
| Financing Cash Flow | $8,241 | $-279 | $4,448 | $-60 | $2,343 |
| Beginning Cash Position | 2,256 | 260 | 2,256 | 260 | 2,256 |
| End Cash Position | 5,061 | 1,369 | 4,659 | 1,500 | 3,409 |
| Net Cash Flow | $2,805 | $1,109 | $2,403 | $1,240 | $1,153 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,599 | 1,641 | -2,225 | 1,441 | -1,692 |
| Capital Expenditure | -19 | -253 | -19 | -141 | N/A |
| Free Cash Flow | -5,618 | 1,388 | -2,244 | 1,300 | -1,692 |